Expert Review of Gastroenterology & Hepatology

Papers
(The TQCC of Expert Review of Gastroenterology & Hepatology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Imaging in pediatric disorders of the gut-brain interactions: current best practice and future directions181
Ripretinib for the treatment of adult patients with advanced gastrointestinal stromal tumors79
Prevention of pancreatitis after stent implantation for distal malignant biliary strictures: systematic review and meta-analysis75
COVID-19 and hygiene hypothesis: increment of the inflammatory bowel diseases in next generation?61
A consensus integrated care pathway for patients with primary biliary cholangitis: a guideline-based approach to clinical care of patients51
Differentiated/undifferentiated mixed type is a prognostic factor for T2/T3 gastric cancer patients45
Managing pain in irritable bowel syndrome: current perspectives and best practice30
Gallbladder carcinosarcoma: current perspectives and new development29
Small bowel transplant – novel indications and recent progress26
Irritable bowel syndrome – controversies in diagnosis and management25
Virologic response maintenance and hepatocellular carcinoma in chronic hepatitis B patients treated with entecavir22
A narrative review on the diagnosis and management of constipation in infants21
ERCP-related adverse events: incidence, mechanisms, risk factors, prevention, and management21
The assessment of impaired liver function and prognosis in hepatocellular carcinoma21
Terlipressin in the management of adults with hepatorenal syndrome-acute kidney injury (HRS-AKI)20
Early alpha-fetoprotein response predicts prognosis of immune checkpoint inhibitor and targeted therapy for hepatocellular carcinoma: a systematic review with meta-analysis20
Therapeutic drug monitoring in inflammatory bowel disease: recent developments20
Recent advances in treating constipation in children18
Lipid biomarkers in colorectal cancer, with particular emphasis on exosomes – current status and future inferences18
Targeting liver metabolism: a pathway to cure hepatitis B virus?14
Investigating the correlation between COVID-19 and the progression of chronic liver disease14
Misinterpretation and misapplication of biomarkers in inflammatory bowel disease: how do we avoid this?14
Altered gut microbiota is associated with sleep disturbances in patients with minimal hepatic encephalopathy caused by hepatitis B-related liver cirrhosis14
Risk of selected gastrointestinal toxicities in metastatic renal cell carcinoma patients treated with immuno-TKI combinations: a meta-analysis14
Identification of a ferroptosis-related gene signature for predicting the prognosis of cholangiocarcinoma14
Familial intestinal polyposis and device assisted enteroscopy: where do we stand?14
Small bowel imaging in inflammatory bowel disease: updates for 202314
Elucidating the role of extracellular vesicles in liver injury induced by HIV14
Bayesian analysis and the role of local palliative therapeutics for malignant biliary obstruction14
An insight into Clostridioides difficile-associated diarrhea in Saudi children: diagnosis and treatment14
Biliary diversion in progressive familial intrahepatic cholestasis: a systematic review and meta-analysis14
Impact of biologic therapies and small molecules on the risk of major adverse cardiovascular events in patients with inflammatory bowel diseases: systematic review and meta-analysis of randomized cont13
Contemporary advances in the endoscopic management of cholangiocarcinoma: a review of accomplished milestones and prospective opportunities13
Characteristic endoscopic findings in Helicobacter pylori diagnosis in clinical practice13
Managing bile acid diarrhea: aspects of contention13
Emerging data on nivolumab for esophageal squamous cell carcinoma13
Chronic nausea and vomiting: a diagnostic approach12
Preoperative endoscopic ultrasound-guided biliary drainage for primary drainage in obstructive jaundice12
Research progress in the role of gut microbiota and its metabolites in intrahepatic cholestasis of pregnancy12
Recent updates on treatment options for primary follicular lymphoma of the gastrointestinal tract12
Vitamin B12 deficiency and use of proton pump inhibitors: a systematic review and meta-analysis12
Percutaneous endoscopic gastrostomy prior to esophagectomy for esophageal cancer – a systematic review and meta-analysis11
Evaluating the role of endoscopic ultrasound in pancreatitis11
Impact of the COVID-19 pandemic on hospitalizations with hepatocellular carcinoma in the United States11
Psychological distress in inflammatory bowel disease11
An update on improving long-term outcomes for patients with chronic pancreatitis post-surgery11
Cost-effectiveness of tislelizumab plus chemotherapy vs chemotherapy as first-line treatment of PD-L1 positive advanced gastric or gastroesophageal junction adenocarcinoma from a Chinese perspective11
Two-dimensional shear wave elastography for sparing endoscopy screening in patients with HBV-related compensated advanced chronic liver disease11
To STRIDE or not to STRIDE: a critique of “treat to target” in ulcerative colitis11
IBD in women of reproductive age: where do novel therapies fit in?11
The role and function of CD4+ T cells in hepatic ischemia-reperfusion injury10
Highlights of the drug-induced liver injury literature for 202110
Relief from behind: enemas, the back door enforcement to help treating chronic constipation in adults10
Managing pediatric Crohn’s disease: recent insights10
High platelet count predicts poor prognosis in HCC patients undergoing TACE: a propensity score-matched analysis10
Diagnosing eosinophilic esophagitis in pediatric patients10
Artificial intelligence implementation in pancreaticobiliary endoscopy10
Gastroesophageal reflux disease in preterm infants: unmet needs9
Managing complications of chronic pancreatitis: a guide for the gastroenterologist9
Germline testing and genetic counseling in biliary tract cancer: an operative proposal to improve the state of art9
Prognostic biomarkers for cholangiocarcinoma (CCA): state of the art9
Interrupting inflammatory bowel disease therapy: why, who, when and how to consider medication holidays9
Investigation of etiology-specific alterations in the gut microbiota in liver cirrhosis9
Towards a better diagnosis of gastro esophageal reflux disease9
Tenofovir versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma: a systematic review and meta-analysis9
Delivering adjuvant and neoadjuvant treatments in the early stages of hepatocellular carcinoma9
Relationship between pathogenic microorganisms and the occurrence of esophageal carcinoma based on pathological type: a narrative review9
Paraneoplastic syndromes in hepatocellular carcinoma: a review9
The efficacy and safety of glucocorticoid for perioperative patients with hepatectomy: a systematic review and meta-analysis8
An update on efficacy and safety comparison of biologics in treatment of inflammatory bowel disease targeting TNF-α, interleukins, leukocyte trafficking, Janus-kinase, and sphingosine-1-phosphate rece8
Cytomegalovirus in ulcerative colitis: an evidence-based approach to diagnosis and treatment8
Cross-regulation between microRNAs and key proteins of signaling pathways in hepatocellular carcinoma8
Highlighting novel targets in immunotherapy for liver cancer8
Development and validation of modified Liaoning score for predicting the prognosis of liver cirrhosis: a retrospective, international multicenter, observational study8
Post-endoscopic submucosal dissection electrocoagulation syndrome: a clinical overview8
Management of disease-related abdominal abscesses in Crohn’s disease8
EUS-guided gastro-enteral anastomosis for the treatment of gastric outlet obstruction: is the end of the enteral stent?8
Updates in interaction of gastroesophageal reflux disease and extragastroesophageal digestive diseases8
Modulating the microbiome in chronic liver diseases – current evidence on the role of fecal microbiota transplantation8
The TL1A inhibitors in IBD: what’s in the pot?8
PSC patient with jaundice – should we ERCP?7
Addition of thermal ablation to systemic chemotherapy for the treatment of unresectable intrahepatic cholangiocarcinoma: a propensity score matching analysis7
Exploring immunological perturbations between hepatocellular carcinoma risk, inflammation and obesity7
Ivosidenib for the treatment of isocitrate dehydrogenase-1 mutant cholangiocarcinoma7
Acute severe ulcerative colitis: defining the precise moment for colectomy7
Endoscopic ultrasound-guided pancreatic duct drainage: a comprehensive state of the art review7
Primary biliary cholangitis: primary autoimmune disease or primary secretory defect7
Effects of probiotics on nonalcoholic fatty liver disease: a systematic review and meta-analysis7
Assessment of efficacy and prognostic factors by Gelfoam for DEB-TACE in unresectable large hepatocellular carcinoma with portal vein tumor thrombus: a multi-center retrospective study7
Novel fibro-inflammatory biomarkers associated with disease activity in patients with Crohn’s disease7
The association between deprivation and the incidence and survival of patients with hepatocellular carcinoma in the West of Scotland7
Medical management of acute severe ulcerative colitis in the hospitalized patient6
Prioritization in inflammatory bowel disease therapy6
Grayscale ultrasonography findings for characterization of gallbladder wall thickening in non-acute setting: a systematic review and meta-analysis6
Mistakes in managing hepatocellular carcinoma and how to avoid them: a narrative review6
Proton beam therapy in the management of hepatocellular carcinoma6
A critical review of upadacitinib for the treatment of adults with moderately to severely active ulcerative colitis6
Induction and maintenance of healing in erosive esophagitis in the United States6
Histamine-producing bacteria and their role in gastrointestinal disorders6
Nutritional aspects of inflammatory bowel disease6
Analysis of the impact on efficacy of lubiprostone dose reduction to manage adverse events in the treatment of chronic constipation in Japan6
Use of fiber-containing enteral formula in pediatric clinical practice: an expert opinion review6
First-line immune checkpoint inhibitor-based combinations in unresectable hepatocellular carcinoma: current management and future challenges6
2023 update on the clinical management of gastroparesis6
Nosocomial spontaneous bacterial peritonitis is associated with high mortality – a systematic review and meta-analysis6
Periodontal and dental health in inflammatory bowel diseases: a systematic review6
The meaning of R1 resection after endoscopic removal of gastric, duodenal and rectal neuroendocrine tumors6
Noninvasive electrical neuromodulation for gastrointestinal motility disorders6
Significance of nucleologenesis, ribogenesis, and nucleolar proteome in the pathogenesis and recurrence of hepatocellular carcinoma6
0.088550806045532